Add to Favorites Newsroom RSS Share
New Haven, CT USA

Our News on Newswise

Yale Cancer Researchers Propose New Ways to Select Patients for Clinical Trials


Yale Cancer Center investigators have demonstrated in a new study that more sophisticated models to assess patient risk for cancer can result in better clinical trials with more definitive results.
24-Jan-2018 2:25 PM EST Add to Favorites

Making Milestones Against Non-Small Cell Lung Cancer


Progress in treating lung cancer has been enormous in the past 20 years according to a new review by researchers at Yale Cancer Center.
22-Jan-2018 11:15 AM EST Add to Favorites

Yale Cancer Center Receives $1 Million Grant to Address Cancer Disparities


Yale Cancer Center (YCC) has been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support.
22-Jan-2018 3:40 PM EST Add to Favorites

Finally, Data About Alternative Medicine and Cancer

According to Altmetric, which tracks the distribution and discussion of research papers online, a July article by several Yale physicians is the most-discussed paper ever published in the Journal of the National Cancer Institute (JNCI). The title of...
18-Jan-2018 3:05 PM EST Add to Favorites

Pediatric Cancer Providers Give Medical Marijuana a Cautious Thumbs-Up


New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are...
11-Dec-2017 12:00 AM EST Add to Favorites

Early Screening for Lung Cancer?


With November Lung Cancer Awareness Month, experts from Yale Cancer Center talk about lung cancer screening and why it is can save lives.
1-Nov-2017 1:05 PM EDT Add to Favorites

Liquid Biopsy, Molecular Testing vs. Reimbursement: A Personal Story

Dr. Rogerio Lilenbaum, a board member of NCCN and Chief Medical Officer of Smilow Cancer Hospital at the Yale Cancer Center said that for nonsmall-cell lung cancer, both panel testing and liquid biopsies are appropriate.
11-Oct-2017 2:05 PM EDT Add to Favorites

Crystallizing Discovery on a Key Target for Cancer Drugs


Yale Cancer Center scientists now have made a fundamental discovery about EGFR signaling, reported in the journal Cell, that may open the potential for new types of cancer drugs.
11-Oct-2017 1:00 PM EDT Add to Favorites

Our Experts on Newswise

Overcoming Resistance to Immunotherapy


For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT

Yale Expert Wins Prestigious 2017 Warren Alpert Prize


6-Oct-2017 2:05 PM EDT

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer


22-Sep-2017 4:30 PM EDT

Expert Discusses Future in Metastatic Lung Cancer Treatment

22-Aug-2017 3:05 PM EDT

Expert to Speak on Bevacizumab in Advanced Head and Neck Cancer

7-Jun-2017 10:20 AM EDT

Treatment of EGFR Mutant Non-Small Cell Lung Cancer

1-Jun-2017 8:05 AM EDT

Yale Cancer Center Researcher Receives Funding From the American Cancer Society for Research Into BRCA2

31-May-2017 11:05 AM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!